{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:19:00Z","timestamp":1795033140534,"version":"4.10.2"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Pelvic inflammatory disease (PID), often caused by sexually transmitted infections (STIs), poses a significant health threat to women of childbearing age (WCBA). This study assessed the global prevalence trends and research landscape of STIs-related PID.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study integrated GBD 2021 data and bibliometric analysis. Joinpoint regression calculated the average annual percentage change (AAPC) for the age-standardized prevalence rate (ASPR) from 1990 to 2021. Decomposition analyses assessed the contributions of population growth, aging, and epidemiological changes to the prevalence trends for the last 32\u00a0years. The Bayesian age\u2013period\u2013cohort model projected ASPR from 2022 to 2040, and the Nordpred model conducted a sensitivity analysis of the prediction results, which validated the findings\u2019 reliability. 1726 related publications were retrieved from the WOS Core Collection database. Bibliometric information was extracted with VOSviewer software for visualization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In 2021, an estimated 1\u00a0009\u00a0957.64 cases of PID due to STIs occurred among WCBA globally, with chlamydial infection accounting for approximately 23%, gonococcal infection (4.98%), and other STIs (72.03%). From 1990 to 2021, the global ASPR of STIs-related PID increased by an AAPC of 0.13%, with the largest increase observed among women in the 20\u201324\u00a0years age group. Regionally, the highest ASPR was observed in low SDI regions in 2021, while the fastest increase occurred in middle SDI regions over the last 32\u00a0years. Decomposition analyses highlighted the population growth as a key driver of the global prevalence rise, accounting for 78.5%. The global ASPR of STIs-related PID is projected to continue rising from 2022 to 2040. Bibliometric analysis showed stable research on STIs and PID, with an increased citation rate. The United States was the leading contributor. Research focused on\n                      <jats:italic toggle=\"yes\">Chlamydia trachomatis<\/jats:italic>\n                      , with recent studies exploring the vaginal microbiome, resistance, and protective immunity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This study performed an epidemiological assessment and bibliometric analysis of the PID attributable to STIs burden globally, informing policy-making and research directions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000004066","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T18:00:54Z","timestamp":1763402454000},"page":"6056-6068","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Global impact of pelvic inflammatory diseases attributable to sexually transmitted infections in women of childbearing age: a comprehensive analysis based on GBD 2021 data and bibliometric analysis"],"prefix":"10.1097","volume":"112","author":[{"given":"Yidan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuixiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanshuo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoneng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6223-0875","authenticated-orcid":false,"given":"Lingli","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"R1-20260417","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/infdis\/jiab116","article-title":"A review of the challenges and complexities in the diagnosis, etiology, epidemiology, and pathogenesis of pelvic inflammatory disease","volume":"224","author":"Hillier","year":"2021","journal-title":"J Infect Dis"},{"key":"R2-20260417","doi-asserted-by":"crossref","first-page":"215\u201318","DOI":"10.31128\/AJGP-09-22-6576","article-title":"Pelvic inflammatory disease and infertility","volume":"52","author":"Hunt","year":"2023","journal-title":"Aust J Gen Pract"},{"key":"R3-20260417","first-page":"73\u201379","article-title":"Association between pelvic inflammatory disease and risk of endometriosis: a systematic review and meta-analysis","volume":"33","author":"Ye","year":"2024","journal-title":"J Womens Health (Larchmt)"},{"key":"R4-20260417","doi-asserted-by":"crossref","first-page":"529\u201337","DOI":"10.1002\/ijc.35180","article-title":"Pelvic inflammatory disease and risk of borderline ovarian tumors: a national population-based case-control study in Sweden","volume":"156","author":"Jonsson","year":"2025","journal-title":"Int J Cancer"},{"key":"R5-20260417","first-page":"397\u2013402","article-title":"Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial","volume":"95","author":"Rein","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R6-20260417","doi-asserted-by":"crossref","first-page":"777\u201393","DOI":"10.1016\/S0889-8545(03)00088-3","article-title":"Pelvic inflammatory disease: new diagnostic criteria and treatment","volume":"30","author":"Beigi","year":"2003","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R7-20260417","doi-asserted-by":"crossref","first-page":"2565\u201369","DOI":"10.1001\/jama.1991.03470180065039","article-title":"Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000","volume":"266","author":"Washington","year":"1991","journal-title":"Jama"},{"key":"R8-20260417","doi-asserted-by":"crossref","first-page":"802\u201315","DOI":"10.1002\/ijgo.16114","article-title":"Comparative clinical and incremental cost-effectiveness analysis of treatments for pelvic inflammatory disease in southern Brazil","volume":"169","author":"Savaris","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"key":"R9-20260417","doi-asserted-by":"crossref","first-page":"102176","DOI":"10.1016\/j.jogoh.2021.102176","article-title":"Characteristics of pelvic inflammatory disease caused by sexually transmitted disease - An epidemiologic study","volume":"50","author":"Yagur","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"R10-20260417","doi-asserted-by":"crossref","first-page":"2039\u201348","DOI":"10.1056\/NEJMra1411426","article-title":"Pelvic inflammatory disease","volume":"372","author":"Brunham","year":"2015","journal-title":"N Engl J Med"},{"key":"R11-20260417","doi-asserted-by":"crossref","first-page":"43\u201349","DOI":"10.1097\/OLQ.0000000000001514","article-title":"Pelvic inflammatory disease trends among emergency department visits in North Carolina, 2008 to 2017","volume":"49","author":"Neo","year":"2022","journal-title":"Sex Transm Dis"},{"key":"R12-20260417","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1093\/infdis\/jiaa771","article-title":"The burden of and trends in pelvic inflammatory disease in the United States, 2006-2016","volume":"224","author":"Kreisel","year":"2021","journal-title":"J Infect Dis"},{"key":"R13-20260417","doi-asserted-by":"crossref","first-page":"534\u201341","DOI":"10.1136\/sextrans-2017-053423","article-title":"Rates of pelvic inflammatory disease and ectopic pregnancy in Australia, 2009-2014: ecological analysis of hospital data","volume":"94","author":"Goller","year":"2018","journal-title":"Sex Transm Infect"},{"key":"R14-20260417","first-page":"2162\u2013203","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R15-20260417","first-page":"2133\u201361","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R16-20260417","doi-asserted-by":"crossref","first-page":"1999\u20132013","DOI":"10.2147\/IJWH.S433516","article-title":"Effect of COVID-19 on menstruation and lower reproductive tract health","volume":"15","author":"Li","year":"2023","journal-title":"Int J Womens Health"},{"key":"R17-20260417","doi-asserted-by":"crossref","first-page":"33\u201339","DOI":"10.1093\/milmed\/usae431","article-title":"Impact of the COVID-19 pandemic on chlamydia, gonorrhea, and pelvic inflammatory disease encounters in a United States uniformed service female beneficiary population","volume":"190","author":"Lehto","year":"2025","journal-title":"Mil Med"},{"key":"R18-20260417","first-page":"173\u201376","article-title":"Bibliometrics: methods for studying academic publishing","volume":"11","author":"Ninkov","year":"2022","journal-title":"Perspect Med Educ"},{"key":"R19-20260417","doi-asserted-by":"crossref","first-page":"112118","DOI":"10.1016\/j.diabres.2025.112118","article-title":"When COVID-19 meets diabetes: a bibliometric analysis","volume":"223","author":"He","year":"2025","journal-title":"Diabet Res Clin Pract"},{"key":"R20-20260417","first-page":"100082","article-title":"Transparency in the Reporting of Artificial Intelligence \u2013 the TITAN Guideline","volume":"2","author":"Riaz","year":"2025","journal-title":"Prem J Sci"},{"key":"R21-20260417","first-page":"2100\u201332","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R23-20260417","first-page":"1989\u20132056","article-title":"Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R24-20260417","doi-asserted-by":"crossref","first-page":"e078432","DOI":"10.1136\/bmj-2023-078432","article-title":"Global burden of type 1 diabetes in adults aged 65 years and older, 1990-2019: population based study","volume":"385","author":"Yang","year":"2024","journal-title":"BMJ"},{"key":"R26-20260417","doi-asserted-by":"crossref","first-page":"335\u201351","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R27-20260417","first-page":"171\u201396","article-title":"Standardization and decomposition of rates from cross-classified data","volume":"50","author":"Das Gupta","year":"1994","journal-title":"Genus"},{"key":"R28-20260417","doi-asserted-by":"crossref","first-page":"429\u201349","DOI":"10.1353\/dem.0.0060","article-title":"Revisiting Das Gupta: refinement and extension of standardization and decomposition","volume":"46","author":"Chevan","year":"2009","journal-title":"Demography"},{"key":"R29-20260417","doi-asserted-by":"crossref","first-page":"567\u201381","DOI":"10.1016\/j.kint.2018.04.011","article-title":"Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016","volume":"94","author":"Xie","year":"2018","journal-title":"Kidney Int"},{"key":"R30-20260417","doi-asserted-by":"crossref","first-page":"102873","DOI":"10.1016\/j.eclinm.2024.102873","article-title":"The global, regional, and national patterns of change in the burden of congenital birth defects, 1990-2021: an analysis of the global burden of disease study 2021 and forecast to 2040","volume":"77","author":"Bai","year":"2024","journal-title":"EClinicalMedicine"},{"key":"R31-20260417","doi-asserted-by":"crossref","first-page":"531\u201349","DOI":"10.1002\/bimj.201500263","article-title":"Projecting the future burden of cancer: Bayesian age-period-cohort analysis with integrated nested Laplace approximations","volume":"59","author":"Riebler","year":"2017","journal-title":"Biom J"},{"key":"R32-20260417","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12874-020-01133-5","article-title":"An R package for an integrated evaluation of statistical approaches to cancer incidence projection","volume":"20","author":"Knoll","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"R33-20260417","doi-asserted-by":"crossref","first-page":"529\u201344","DOI":"10.1093\/humrep\/deae292","article-title":"Global, regional, and national prevalence and trends of infertility among individuals of reproductive age (15-49 years) from 1990 to 2021, with projections to 2040","volume":"40","author":"Liang","year":"2025","journal-title":"Hum Reprod"},{"key":"R34-20260417","doi-asserted-by":"crossref","first-page":"1285\u2013306","DOI":"10.1016\/S0140-6736(20)30677-2","article-title":"Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study","volume":"396","author":"Vollset","year":"2020","journal-title":"Lancet"},{"key":"R35-20260417","doi-asserted-by":"crossref","first-page":"541\u201351","DOI":"10.1016\/S1473-3099(21)00448-5","article-title":"Global burden and trends of sexually transmitted infections from 1990 to 2019: an observational trend study","volume":"22","author":"Zheng","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"R36-20260417","doi-asserted-by":"crossref","first-page":"g1538","DOI":"10.1136\/bmj.g1538","article-title":"Why is the incidence of pelvic inflammatory disease falling?","volume":"348","author":"Ross","year":"2014","journal-title":"BMJ"},{"key":"R37-20260417","doi-asserted-by":"crossref","first-page":"1327\u201329","DOI":"10.2105\/AJPH.94.8.1327","article-title":"Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease","volume":"94","author":"Ness","year":"2004","journal-title":"Am J Public Health"},{"key":"R38-20260417","doi-asserted-by":"crossref","first-page":"2299\u2013313","DOI":"10.1007\/s10461-021-03573-6","article-title":"A trend analysis of condom use in Spanish Young People over the two past decades, 1999-2020","volume":"26","author":"Ballester-Arnal","year":"2022","journal-title":"AIDS Behav"},{"key":"R39-20260417","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12978-020-00987-8","article-title":"Associated factors and sex differences in condom non-use among adolescents: Brazilian National School Health Survey (PeNSE)","volume":"17","author":"Noll","year":"2020","journal-title":"Reprod Health"},{"key":"R40-20260417","doi-asserted-by":"crossref","first-page":"104281","DOI":"10.1016\/j.drugpo.2023.104281","article-title":"On-site testing and treatment of sexually transmitted infections among female sex workers using molecular point-of-care testing integrated into harm reduction services in Madrid, Spain","volume":"123","author":"Valencia","year":"2024","journal-title":"Int J Drug Policy"},{"key":"R41-20260417","first-page":"217\u201323","article-title":"Estimated burden of Chlamydia trachomatis female infection and consequent severe pelvic inflammatory disease, Italy, 2005-2016","volume":"55","author":"Sabbatucci","year":"2019","journal-title":"Ann Ist Super Sanita"},{"key":"R42-20260417","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/S1473-3099(17)30310-9","article-title":"Sexually transmitted infections: challenges ahead","volume":"17","author":"Unemo","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"R43-20260417","doi-asserted-by":"crossref","first-page":"106785","DOI":"10.1016\/j.ijantimicag.2023.106785","article-title":"Multicentre clinical evaluation of a molecular diagnostic assay to identify Neisseria gonorrhoeae infection and detect antimicrobial resistance","volume":"61","author":"Xiu","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"R44-20260417","doi-asserted-by":"crossref","first-page":"753\u201359","DOI":"10.1080\/14787210.2024.2401560","article-title":"Alternative drugs for the treatment of gonococcal infections: old and new","volume":"22","author":"Franco","year":"2024","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R45-20260417","doi-asserted-by":"crossref","first-page":"100737","DOI":"10.1016\/j.lanepe.2023.100737","article-title":"Treatment of bacterial sexually transmitted infections in Europe: gonorrhoea, Mycoplasma genitalium, and syphilis","volume":"34","author":"Mitj\u00e0","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"R46-20260417","doi-asserted-by":"crossref","first-page":"1035841","DOI":"10.3389\/fphar.2022.1035841","article-title":"Pharmacodynamic evaluation of lefamulin in the treatment of gonorrhea using a hollow fiber infection model simulating Neisseria gonorrhoeae infections","volume":"13","author":"Jacobsson","year":"2022","journal-title":"Front Pharmacol"},{"key":"R47-20260417","doi-asserted-by":"crossref","first-page":"504\u201312","DOI":"10.1093\/cid\/ciy145","article-title":"Gepotidacin for the treatment of uncomplicated urogenital gonorrhea: a Phase 2, randomized, dose-ranging, single-oral dose evaluation","volume":"67","author":"Taylor","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R48-20260417","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12879-020-04980-1","article-title":"Phase II trial evaluating the clinical efficacy of cefixime for treatment of active syphilis in non-pregnant women in Brazil (CeBra)","volume":"20","author":"Taylor","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R49-20260417","doi-asserted-by":"crossref","first-page":"404\u201316","DOI":"10.1016\/S1473-3099(23)00683-7","article-title":"Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trial","volume":"24","author":"Ubals","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"R50-20260417","doi-asserted-by":"crossref","first-page":"873\u201380","DOI":"10.1002\/pds.3467","article-title":"Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD)","volume":"22","author":"Mikolajczyk","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000004066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:00:31Z","timestamp":1776423631000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000004066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000004066","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"2025-07-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}